Dimitrios G. Gkotsoulias

Dimitrios G. Gkotsoulias

Auto-generated profile, based on publicly available information

Dimitrios G. Gkotsoulias

Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University of Basel, Basel, Switzerland; Translational Imaging in Neurology Basel, Department of Biomedical Engineering, Faculty of Medicine, University of Basel, Allschwil, Switzerland; Department of Neurology, University Hospital Basel, Basel, Switzerland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2025 in Brain Communications
Verified
Journal Article
Open access
DGDimitrios G Gkotsoulias
Dimitrios G Gkotsoulias
MRMichael Rullmann
Michael Rullmann
SSSimon Schmitt
Simon Schmitt
ABAnna Bujanow
Anna Bujanow
FZFranziska Zientek
Franziska Zientek
HMHarald E Möller
Harald E Möller
While the implication of a dysfunctional dopaminergic system in Tourette syndrome (TS) is well established, the underlying pathophysiological mechanisms remain unclear. Apart from neurotransmitters, disturbed iron homeostasis and iron regulatory mechanisms are also suspected. Iron is a trace element of fundamental biological importance and is involved in the synthesis and metabolism of dopamine and its receptors and transporters. The goal of the current pre-registered, multi-modal, cross-sectional study was to investigate the relationship between potential iron homeostasis imbalances and dopaminergic system disturbances in patients with TS. Susceptibility-sensitive MRI at 7 Tesla was used to obtain surrogate measures for local brain iron in 25 patients with TS (age 30 ± 9 years, 6 female) and 40 matched control subjects. Additionally, dopamine D1 receptor availability was investigated with [11C]SCH23390 PET in a subgroup of 20 patients and 20 controls. Significantly reduced sub-cortical magnetic susceptibility, indicating reduced iron levels, was observed in TS patients in the caudate, pallidum, sub-thalamic nucleus, thalamus, red nucleus and substantia nigra. These reductions were accompanied by significant reductions of the [11C]SCH23390 binding potential indicating reduced availability of D1 receptors in the dorsal striatum. The D1 receptor abnormality correlated with tic severity. These results point to alterations of intra-synaptic dopamine release and reduced striatal D1 receptor binding, supporting the notion of disruption in multiple functional elements of the dopaminergic system. Such dopaminergic abnormalities appear to be associated with disturbances in iron homeostasis.

20 November 2025 in STAR Protocols
Verified
Journal Article
Open access
DGDimitrios G. Gkotsoulias
Dimitrios G. Gkotsoulias
LSLukas Schönenberger
Lukas Schönenberger
JLJochen Leupold
Jochen Leupold
ICIlaria Callegari
Ilaria Callegari
EBErik Bahn
Erik Bahn
CGCristina Granziera
Cristina Granziera
Combining ex vivo MRI mesoscopic and histopathology microscopic assessments of tissue microstructure forms a key approach in multiple sclerosis (MS) research for elucidating disease pathogenesis. We present a protocol that enables reproducible, scalable, and robust integration of MRI and histology data in MS brains. We describe steps for (1) obtaining high-resolution multi-contrast 9.4T MRI of postmortem brain blocks and (2) the usage of a custom, open-source image processing interface for robust histology-MRI registration and semi-quantitative mapping of myelin density, microglia, and cell count.

16 July 2025 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
DGDimitrios G. Gkotsoulias
Dimitrios G. Gkotsoulias
MWMatthias Weigel
Matthias Weigel
ACAlessandro Cagol
Alessandro Cagol
NSNina de Oliveira Soares Siebenborn
Nina de Oliveira Soares Siebenborn
EREsther Ruberte
Esther Ruberte
CGCristina Granziera
Cristina Granziera
Background: Quantitative susceptibility mapping (QSM) has emerged as a promising paraclinical tool in multiple sclerosis (MS). This retrospective pilot study aims to evaluate whether a recently proposed deep learning-assisted, k-space-operating reconstruction, denoising and super-resolution technique (DLR) applied on 3D-echo-planar-imaging (3DEPI) protocols, has the potential to improve the quality and clinical utility of QSM in MS, at 3T. Secondarily, we assess whether applying DLR vs. a conventional reconstruction (CR) can improve the quality of QSM based on noise-susceptible, fast 3DEPI protocols.Methods: 3T MRI 3DEPI-data were acquired on seven MS patients and offline-reconstructed using CR and DLR. A sample size of 433 lesions was identified, based on FLAIR segmentation. Two experts, independently and method-blinded, rated lesion-wise the CR- and DLR-3DEPI-derived QSM, assessing the confidence in identifying paramagnetic rim lesions (PRLs), central vein sign (CVS), QSM hyper/isointense lesions and image quality. Gradient-recalled-echo (GRE), 2- and 1-average 3DEPI (acquisition time: 7:02, 3:44, and 1:56 min, respectively) from a healthy individual were offline-reconstructed using CR and DLR. Derived QSM maps were compared visually and quantitatively.Results: Deep learning reconstruction-3DEPI-based QSM was rated significantly higher for the confidence in identification of the MS-specific biomarkers (hyper/isointense lesions: P < 0.001, CVS: P = 0.01) and overall image quality (P < 0.001), compared to CR-3DEPI-based. Inter-method agreement was high for both raters (Cohen’s κ = 0.98/0.92), suggesting that DLR improves the quality without changing the rater’s perception of the individual QSM-related clinical findings. Additionally, QSM derived from fast DLR-3DEPI with a fourfold acquisition-time reduction compared to GRE, exhibited excellent visual and quantitative consistency with GRE-based QSM.Conclusion: Our results constitute a first demonstration of the enhanced quality and clinical utility of the DLR-3DEPI-based QSM in MS.